Loading…

Thermo Fisher Scientific completed its acquisition of PPD, a clinical research services provider, for $17.4 billion on December 8, 2021.
“Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has completed its acquisition of PPD, Inc. (Nasdaq: PPD), a leading global provider of clinical research services to the biopharma and biotech industry, for $17.4 billion.”ir.thermofisher.com
Summarized from public sources; check the original articles before acting on it.